期刊文献+

类固醇生成因子1和DAX-1在肾上腺皮质肿瘤中的表达及临床意义 被引量:2

Expression of steroidogenic factor-1 and DAX-1 in human adrenocortical tumours
原文传递
导出
摘要 目的 探讨类固醇生成因子1(SF-1)和DAX-1在肾上腺皮质肿瘤中的表达及其临床意义.方法 应用实时荧光定量PCR检测39例肾上腺皮质肿瘤:包括对血管紧张素Ⅱ无反应的醛固酮瘤(AⅡ-U-APA)12例、有反应的醛固酮瘤(AⅡ-R-APA)5例、分泌醛固酮的肾上腺皮质癌2例、皮质醇瘤10例、肾上腺无功能瘤10例及8例正常肾上腺皮质的SF-1、DAX-1、ACTH受体和内参β3-actin mRNA的表达.应用Western印迹检测SF-1和DAX-1蛋白在上述组织中的表达,比较不同组织中SF-1、DAX-1mRNA及蛋白表达的差异.对SF-1和DAX-1在肾上腺皮质肿瘤中的表达差异与患者的临床资料行相关性分析.结果 SF-1和DAX-1 mRNA及蛋白在正常肾上腺皮质、AⅡ-U-APA、AⅡ-R-APA、肾上腺皮质醛固酮癌、皮质醇瘤和无功能瘤中的表达存在差异[ SF-1 mRNA相对值:24.58±2.45、23.89±3.17、21.59±3.00、(38.75,44.16)、14.17±2.80和36.38±3.50; DAX-1 mRNA:0.57 ±0.06、0.37±0.05、0.43±0.05、(1.52,1.21)、0.39±0.04和0.83 ±0.08:SF-1蛋白:0.76±0.11、0.76±0.10、0.73±0.07、(1.24,1.40)、0.55±0.04和0.98±0.10:DAX-1蛋白:0.65±0.14、0.39±0.13、0.43±0.14、(1.18,1.02)、0.56±0.04和1.03±0.13;均P<0.05或P<0.01];AⅡ-U-APA组织中SF-1正常、DAX-1表达减低、SF-1/DAX-1比值增高且与醛固酮瘤的大小呈明显负相关;SF-1在皮质醇瘤中明显低表达,且与皮质醇瘤大小呈正相关;SF-1和DAX-1 mRNA及蛋白在肾上腺无功能皮质瘤中高表达、在肾上腺醛固酮分泌癌中表达有明显高于其他各组的趋势、而在嗜铬细胞瘤中无表达.结论 SF-1和DAX-1在不同肾上腺皮质肿瘤中表达各异,提示他们可能参与肾上腺皮质肿瘤的生长和激素分泌. Objective To detect mRNA and protein expression of steroidogenic factor-1 ( SF-1 ) and DAX-1 in human adrenocortical tumors and normal adrenal cortex,and to investigate the effect of SF-1 and DAX-1 on the steroidogenesis and development of adrenocortical tumors.Methods Total RNA and protein was extracted from angiotensin Ⅱ unresponsive aldoterone-producing adenomas ( A Ⅱ -U-APA,n =12 ),angiotensin Ⅱ responsive aldoterone-producing adenomas ( AⅡ -R-APA,n =5 ),cortisol-producing adenomas ( CPA,n =10 ),adrenal nonfunctional adenomas ( NFA,n =10 ),aldosterone-producing carcinoma ( APC,n =2 ) and normal adrenal cortex ( NAC,n =8).To analyze gene expression of SF-1,DAX-1,ACTH receptor(ACTHR),and β-actin by real-time quantitative PCR in different tissues.The protein expression of SF-1,DAX-1,and β-actin in the same tissues by Western blot.To study the relationship of ACTHR,SF-1,and DAX-1 with clinical data in adrenocortical tumors.Results The expression of SF-1,DAX-1 mRNA and protein was different in NAC,AⅡ -U-APA,A Ⅱ -R- APA,APC,CPA,and NFA tissues [ relative expression of SF-1 mRNA:24.58±2.45,23.89±3.17,21.59±3.00,(38.75,44.16),14.17±2.80,and 36.38±3.50; DAX-1 mRNA:0.57±0.06,0.37±0.05,0.43±0.05,( 1.52,1.21 ),0.39 ±0.04,and 0.83 ±0.08 ; SF-1 protein:0.76 ±0.11,0.76 ±0.10,0.73 ±0.07,(1.24,1.40),0.55±0.04,and0.98±0.10; DAX-1 protein:0.65±0.14,0.39±0.13,0.43±0.14,(1.18,1.02),0.56±0.04,and 1.03±0.13 ; all P〈0.05 or P〈0.01 ].There was negative correlation by higher SF-1/DAX-1 ratio and tumor size in AⅡ -U-APA tissues.The mRNA and protein expression of SF-1 was lower in CPA and there was the positive correlation with tumor size.Conclusion SF-1 and DAX-1 might play a key role in the development of the adrenocortical tumorigenesis and steroidogenic tissues.
机构地区 中国医学科学院
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第2期103-107,共5页 Chinese Journal of Endocrinology and Metabolism
基金 高等学校博士学科点专项科研基金(20091106110013)
关键词 类固醇生成因子1 DAX-1 肾上腺皮质肿瘤 实时荧光定量PCR WESTERN印迹 Steroidogenic factor-1 DAX-1 Adrenocortical tumors Real-time quantitative PCR Western blot
  • 相关文献

参考文献21

  • 1Crawford PA,Dorn C,Sadovsky Y,et al.Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1.Mol Cell Biol,1998,18:2949-2956. 被引量:1
  • 2Doghman M,Karpova T,Rodrigues GA,et al.Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer.Mol Endocrinol,2007,21:2968-2987. 被引量:1
  • 3NakamuraY,Suzuki T,Arai Y,et al.Nuclear receptor DAX1 in human prostate cancer:a novel independent biological modulator.Endocr J,2009,56:39-44. 被引量:1
  • 4Helguero LA,Hedengran-Faulds M,F(o)rster C,et al.DAX-1 expression is regulated during mammary epithelial cell differentiation. Endocrinology.2006,147:3249-3259. 被引量:1
  • 5SaitoS,Ito K,Suzuki T,et al.Orphan nuclear receptor DAX-l in human endometrium and its disorders.Cancer Sci,2005,96:645-652. 被引量:1
  • 6Gordon RD.Primary aldosteronism.J Endocrinol Invest,1995,495-511. 被引量:1
  • 7Beuschlein F,Keegan CE,Bavers DL,et al.SF-1,DAX-1,and acd:molecular determinants of adrenocortical growth and steroidogenesis.Endocr Res,2002,28:597-607. 被引量:1
  • 8Lalli E,Melner MH,Stocco DM,et al. DAX-1 blocks steroid production at multiple levels.Endocrinology,1998,139:4237-4243. 被引量:1
  • 9Shibata H,Ikeda Y,Mukai T,et al.Expression profiles of COUP-TF,DAX-1,and SF-1 in the human adrenal gland and adrenocortical tumors:Possible implications in steroidogenesis.Mol Genet Metab,2001,74:206-216. 被引量:1
  • 10Ragazzon B,Lefrancois-Martinez AM,Val P,et al.Adrenocorticotropindependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis.Endocrinology,2006,147:1805-1818. 被引量:1

二级参考文献16

共引文献5

同被引文献47

  • 1Sbiera S, Schmull S, Assie G, et al. High diagnostic and prognostic value of steroidogenic factor-I expression in adrenal tumors. J Clin Endocrinol Metab, 2010,95 : E161-E171. 被引量:1
  • 2Carey RM. Adrenal disease update 2011. J Clin Endocrinol Metab, 2011,96:3583-3591. 被引量:1
  • 3Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science, 2011,331:768-772. 被引量:1
  • 4Funder JW. The genetics of primary aldosteronism. Science, 2011,33 l : 685-686. 被引量:1
  • 5Bandulik S,Penton D, Barhanin J, et al. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortic- zonation. Hom- Metab Res, 2010,42:450-457. 被引量:1
  • 6onoyama T, Sone M, Miyashita K, et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone- producing adenoma. J Clin Endocrinol Metah, 2011,96:2771-2778. 被引量:1
  • 7Burton TJ, Mackenzie IS, Balan K, et al. Evaluation of the sensitivity and specificity of I J C-mctomidate positron emission tomography ( PET ) -CT for lateralizing aldosterone secretion by Corm' s adenoma. J Clin Endocrinol Metab, 2012,97 : 100-109. 被引量:1
  • 8Kamenicky P, Droumaguet C, Salenave S, et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. J Clin Endocrine Metab, 2011,96:2796-2804. 被引量:1
  • 9Nieinan LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab, 2010,95:4106-4l 13. 被引量:1
  • 10Chiodini I, Morelli V, Salcuni AS, et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab, 2010, 95,2736 -2745. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部